The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele
Open accessAbstract
A common T17A polymorphism in the signal peptide of the cytotoxic T-lymphocyte antigen 4 (CTLA-4), a T-cell receptor that negatively regulates immune responses, is associated with risk for autoimmune disease. Because the polymorphism is absent from the mature protein, we hypothesized that its biological effect must involve early stages of protein processing, prior to signal peptide cleavage. Constructs representing the two alleles were compared by in vitro translation, in the presence of endoplasmic reticulum membranes. We studied glycosylation by endoglycosidase H digestion and glycosylation mutant constructs, cleavage of peptide with inhibitors, and membrane integration by ultracentrifugation and proteinase K sensitivity. A major cleaved and glycosylated product was seen for both alleles of the protein but a band representing incomplete glycosylation was markedly more abundant in the predisposing Ala allele (32.7 +/- 1.0 versus 10.6% +/- 1.2 for Thr, p < 10(-9)). In addition, differential intracellular/surface partitioning was studied with co-transfection of the alleles fused to distinct fluorescent proteins in COS-1 cells. By quantitative confocal microscopy we found a higher ratio of cell surface/total CTLAThr(17) versus CTLAAla(17) (p = 0.01). Our findings corroborate observations, in other proteins, that the signal peptide can determine the efficiency of post-translational modifications other than cleavage and suggest inefficient processing of the autoimmunity predisposing Ala allele as the explanation for the genetic effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,843
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von Heijne, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,356
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Setting the Standards: Quality Control in the Secretory Pathway
Ellgaard, L., Molinari, M., & Helenius, A. (1999) · Science · doi:10.1126/science.286.5446.1882 · Cited by 1,192
Hidden Markov models for detecting remote protein homologies.
Karplus, K., Barrett, C., & Hughey, R. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.10.846 · Cited by 1,102
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
Nistico, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.1075 · Cited by 809
Gavel, Y., & Heijne, G. V. (1990) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/3.5.433 · Cited by 751
Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement
Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., & Abbas, A. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80284-8 · Cited by 716
Molecular Basis of T Cell Inactivation by CTLA-4
Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., & Bluestone, J. A. (1998) · Science · doi:10.1126/science.282.5397.2263 · Cited by 684
Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR Engagement
Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L., & Mittler, R. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80480-x · Cited by 609
Kouki, T., Sawai, Y., Gardine, C. A., Fisfalen, M.-E., Alegre, M.-L., & DeGroot, L. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6606 · Cited by 505
CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
Yanagawa, T. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.41 · Cited by 465
Chambers, C. A., Sullivan, T. J., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80406-9 · Cited by 411
Marron, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1275 · Cited by 407
CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus1
Donner, H., Rau, H., Walfish, P. G., Braun, J., Siegmund, T., Finke, R., Herwig, J., Usadel, K. H., & Badenhoop, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3699 · Cited by 396
CTLA-4: a negative regulator of autoimmune disease.
Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.783 · Cited by 376
Shakin-Eshleman, S. H., Spitalnik, S. L., & Kasturi, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6363 · Cited by 318
Mäurer, S. L. (2002) · Immunogenetics · doi:10.1007/s00251-002-0429-9 · Cited by 294
Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
Lühder, F., Höglund, P., Allison, J. P., Benoist, C., & Mathis, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.427 · Cited by 290
A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism
Kotsa, K., Watson, P. F., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1710996.x · Cited by 258
Donner, H., Braun, J., Seidl, C., Rau, H., Finke, R., Ventz, M., Walfish, P. G., Usadel, K. H., & Badenhoop, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4406 · Cited by 241
Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous
Bachmann, M. F., Köhler, G., Ecabert, B., Mak, T. W., & Kopf, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1128 · Cited by 235
Perrin, P. J., Maldonado, J. H., Davis, T. A., June, C. H., & Racke, M. K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1333 · Cited by 226
CTLA-4 gene polymorphism is associated with predisposition to coeliac disease
Djilali-Saiah, I., Schmitz, J., Harfouch-Hammoud, E., Mougenot, J.-F., Bach, J.-F., & Caillat-Zucman, S. (1998) · Gut · doi:10.1136/gut.43.2.187 · Cited by 220
The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
Vaidya, B. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1195 · Cited by 217
Leung, H. T., Bradshaw, J., Cleaveland, J. S., & Linsley, P. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25107 · Cited by 191
Panning for gold: genome-wide scanning for linkage in type 1 diabetes
Todd, J. A., & Farrall, M. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1443 · Cited by 170
CTLA-4 Regulates Tolerance Induction and T Cell Differentiation In Vivo
Walunas, T. L., & Bluestone, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3855 · Cited by 166
CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production
Tomer, Y., Greenberg, D. A., Barbesino, G., Concepcion, E., & Davies, T. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7372 · Cited by 163
Kasturi, L., Eshleman, J. R., Wunner, W. H., & Shakin-Eshleman, S. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14756 · Cited by 161
The Development of Graves’ Disease and theCTLA-4Gene on Chromosome 2q331
Heward, J. M., Allahabadia, A., Armitage, M., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5820 · Cited by 153
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
Metzler, W. J., Bajorath, J., Fenderson, W., Shaw, S., Constantine, K. L., Naemura, J. R., Leytze, G., Peach, R., Lavoie, T., Mueller, L., et al. (1997) · Nature Structural Biology · doi:10.1038/nsb0797-527 · Cited by 147
Awata, T., Kurihara, S., Iitaka, M., et al. (1998) · Diabetes · doi:10.2337/diab.47.1.128 · Cited by 144
CTLA4 Gene Polymorphism Confers Susceptibility to Graves' Disease in Japanese
Yanagawa, T., Taniyama, M., Enomoto, S., Gomi, K., Maruyama, H., Ban, Y., & Saruta, T. (1997) · Thyroid · doi:10.1089/thy.1997.7.843 · Cited by 136
Vaidya, B., Pearce, S. H. S., Charlton, S., Marshall, N., Rowan, A. D., Griffiths, I. D., Kendall-Taylor, P., Cawston, T. E., & Young-Min, S. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.2.180 · Cited by 135
Marron, M. P., Zeidler, A., Raffel, L. J., Eckenrode, S., Yang, J. J., Hopkins, D. I., Garchon, H., Jacob, C. O., Serrano‐Ríos, M., Larrad, M. T. M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.492 · Cited by 124
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance
Eagar, T. N., Karandikar, N. J., Bluestone, J. A., & Miller, S. D. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<972::aid-immu972>3.0.co;2-m · Cited by 114
AUWERA, B. J. V. D., VANDEWALLE, C. L., SCHUIT, F. C., WINNOCK, F., LEEUW, I. H. D., IMSCHOOT, S. V., LAMBERIGTS, G., GORUS, F. K., & the Belgian Diabetes Registry (1997) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1997.t01-1-512-ce1410.x · Cited by 113
Kemp, E. H., Ajjan, Husebye, Peterson, P., Uibo, R., Imrie, Pearce, Watson, & Weetman (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00579.x · Cited by 112
Hurwitz, A. A., Sullivan, T. J., Krummel, M. F., Sobel, R. A., & Allison, J. P. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00168-3 · Cited by 110
Karaplis, A. C., Lim, S., Baba, H., Arnold, A., & Kronenberg, H. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1629 · Cited by 108
Ito, M., Oiso, Y., Murase, T., Kondo, K., Saito, H., Chinzei, T., Racchi, M., & Lively, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116494 · Cited by 105
Competition between folding and glycosylation in the endoplasmic reticulum.
Holst, B., Bruun, A. W., Kielland‐Brandt, M. C., & Winther, J. R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00723.x · Cited by 104
Relation of three polymorphisms of the CTLA-4 gene in patients with Graves’ disease
Kouki, T., Gardine, C. A., Yanagawa, T., & DeGroot, L. J. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343992 · Cited by 98
Li, Y. X., Bergeron, J. J. M., Luo, L., Ou, W. J., Thomas, D. Y., & Kang, C. Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9606 · Cited by 86
Barrat, F. J., Deist, F. L., Benkerrou, M., Bousso, P., Feldmann, J., Fischer, A., & Basile, G. D. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8645 · Cited by 84
Polymorphism of the CTLA-4 Gene Is Associated with Autoimmune Hypothyroidism in the United Kingdom
Nithiyananthan, R., Heward, J. M., Allahabadia, A., Franklyn, J. A., & Gough, S. C. L. (2002) · Thyroid · doi:10.1089/105072502753451896 · Cited by 82
Beuret, N., Rutishauser, J., Bider, M. D., & Spiess, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18965 · Cited by 77
Barbesino, G., Tomer, Y., Concepcion, E., Davies, T. F., & Consort, D. A. G. T. I. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1580 · Cited by 67
Racchi, M., Watzke, H., High, K. A., & Lively, M. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53380-9 · Cited by 62
Technical Note: Linkage Disequilibrium and Disease-Associated CTLA4 Gene Polymorphisms
Holopainen, P., & Partanen, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2457 · Cited by 59
CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families
King, A. L., Moodie, S. J., Fraser, J., Curtis, D., Reid, E., Dearlove, A., Ellis, H. J., & Ciclitira, P. J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.51 · Cited by 57
Karandikar, N. J., Eagar, T. N., Vanderlugt, C. L., Bluestone, J. A., & Miller, S. D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00322-2 · Cited by 55
Cited by
Immune checkpoint signaling and cancer immunotherapy
He, X., & Xu, C. (2020) · Cell Research · doi:10.1038/s41422-020-0343-4 · Cited by 1,371
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 542
A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION
Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 518
Metadata
- Authors
- Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M.-C., & Polychronakos, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 48
- Pages
- 46478-46486
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2065899910
- Cited by
- 293
- References
- 57
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.